Stay updated on Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision metadata on the page was updated from v3.6.5 to v3.6.6, indicating a minor version update to the page’s backend or documentation. This change does not modify the study content or data presented on the page.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision label was updated to v3.6.5, indicating a new site build rather than changes to the study details.SummaryDifference0.0%

- Check43 days agoChange DetectedIPD (Individual Participant Data) data-sharing plan added and related terminology updated. Study Protocol and Statistical Analysis Plan are now linked, and MeSH terms and record history metadata expanded to improve indexing and transparency of the trial record.SummaryDifference78%

- Check50 days agoChange DetectedA new revision tag (Revision: v3.6.4) is shown, and several non-core study documents/listings were removed from the study record, reflecting a documentation cleanup on the page.SummaryDifference21%

- Check72 days agoChange DetectedThe page revision has been updated from v3.6.2 to v3.6.3, reflecting a newer version of the page content. The change does not modify displayed study information.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the study documents or page metadata.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab +/- SD-101 in Oligometastatic Prostate Cancer Clinical Trial page.